Immuron Limited (DE:ANW)
FRANKFURT:ANW
Holding DE:ANW?
Track your performance easily

Immuron Limited (ANW) Stock Price & Analysis

1 Followers

ANW Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.27%99.73%
― Other Institutional Investors
99.73% Public Companies and
Individual Investors

ANW FAQ

What was Immuron Limited’s price range in the past 12 months?
Immuron Limited lowest stock price was €0.03 and its highest was €0.11 in the past 12 months.
    What is Immuron Limited’s market cap?
    Currently, no data Available
    When is Immuron Limited’s upcoming earnings report date?
    Immuron Limited’s upcoming earnings report date is Feb 26, 2025 which is in 113 days.
      How were Immuron Limited’s earnings last quarter?
      Immuron Limited released its earnings results on Aug 30, 2024. The company reported €0 earnings per share for the quarter, the consensus estimate of N/A by €0.
        Is Immuron Limited overvalued?
        According to Wall Street analysts Immuron Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Immuron Limited pay dividends?
          Immuron Limited does not currently pay dividends.
          What is Immuron Limited’s EPS estimate?
          Immuron Limited’s EPS estimate is €0.
            How many shares outstanding does Immuron Limited have?
            Immuron Limited has 229,145,430 shares outstanding.
              What happened to Immuron Limited’s price movement after its last earnings report?
              Immuron Limited reported an EPS of €0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Immuron Limited?
                Currently, no hedge funds are holding shares in DE:ANW
                ---

                Immuron Limited Stock Smart Score

                Company Description

                Immuron Limited

                Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                MOBOTIX AG
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis